Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela D'Angelo

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
Journal of Clinical Psychopharmacology|February 15, 2021
Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive PatientsAlfredo Costa, Angela D'Angelo, Matteo Cotta Ramusino, et al.
International Journal of Molecular Medicine|May 13, 2004
Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's diseaseEnzo Emanuele, Emmanouil Peros, Giuseppe A Scioli, et al.
Archives of Medical Science : AMS|May 17, 2017
Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathyDaniele Bosone, Alfredo Costa, Natascia Ghiotto, et al.
American Journal of Nephrology|March 16, 2004
Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patientsEnzo Emanuele, Luigi Segagni Lusignani, Emmanouil Peros, et al.
Atherosclerosis|August 9, 2005
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery diseaseEnzo Emanuele, Colomba Falcone, Angela D'Angelo, et al.
Expert Opinion on Drug Safety|July 3, 2013
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapiesGiuseppe Derosa, Arrigo Francesco Giuseppe Cicero, Anna Carbone, et al.
Current Vascular Pharmacology|June 1, 2011
Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapiesMaria Fusaro, Gaetano Crepaldi, Stefania Maggi, et al.
International Journal of Molecular Medicine|March 9, 2005
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosusEmmanouil Peros, Diego Geroldi, Serena Bugatti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammationGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapiesGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
Journal of Clinical Psychopharmacology|February 15, 2021
Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive PatientsAlfredo Costa, Angela D'Angelo, Matteo Cotta Ramusino, et al.
International Journal of Molecular Medicine|May 13, 2004
Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's diseaseEnzo Emanuele, Emmanouil Peros, Giuseppe A Scioli, et al.
Archives of Medical Science : AMS|May 17, 2017
Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathyDaniele Bosone, Alfredo Costa, Natascia Ghiotto, et al.
American Journal of Nephrology|March 16, 2004
Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patientsEnzo Emanuele, Luigi Segagni Lusignani, Emmanouil Peros, et al.
Atherosclerosis|August 9, 2005
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery diseaseEnzo Emanuele, Colomba Falcone, Angela D'Angelo, et al.
Expert Opinion on Drug Safety|July 3, 2013
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapiesGiuseppe Derosa, Arrigo Francesco Giuseppe Cicero, Anna Carbone, et al.
Current Vascular Pharmacology|June 1, 2011
Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapiesMaria Fusaro, Gaetano Crepaldi, Stefania Maggi, et al.
International Journal of Molecular Medicine|March 9, 2005
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosusEmmanouil Peros, Diego Geroldi, Serena Bugatti, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammationGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapiesGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Pageof 20